| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 12/06/2007 | WO2007061281A3 Prevention and treatment of porcine reproductive and respiratory syndrome (prrs) |
| 12/06/2007 | WO2007047791A3 Monomeric self-associating fusion polypeptides and therapeutic uses thereof |
| 12/06/2007 | WO2007002534A3 Thrombospondin-1 derived peptides and treatment methods |
| 12/06/2007 | WO2006130689A3 Detecting prostate cancer |
| 12/06/2007 | WO2005086612A3 Fluorinated carbohydrate conjugates |
| 12/06/2007 | WO2005080436A3 Antibodies that bind pote and uses thereof |
| 12/06/2007 | WO2005079515A3 Conformation specific antibodies |
| 12/06/2007 | WO2005072254A3 Modulation of sulfate permease for photosynthetic hydrogen production |
| 12/06/2007 | WO2005044994A3 High temperature and alkaline stable catalase |
| 12/06/2007 | WO2004078141A3 Hemipteran membrane-bound matrix metalloproteinase |
| 12/06/2007 | WO2004074460A3 Nucleotide and protein sequences of coc genes and methods based thereon |
| 12/06/2007 | WO2004060304A3 Novel compositions and methods in cancer |
| 12/06/2007 | WO2004052233A3 Canine rankl and methods for preparing and using the same |
| 12/06/2007 | WO2003023001A3 Novel proteins and nucleic acids encoding same |
| 12/06/2007 | US20070282015 Novel Splice Variants of Human Dkkl1 |
| 12/06/2007 | US20070281896 Novel compositions and methods in cancer |
| 12/06/2007 | US20070281895 Molecular Marker |
| 12/06/2007 | US20070281890 Fibroblast Growth Factor-13 |
| 12/06/2007 | US20070281365 Crystal Structure of Erbb2 and Uses Thereof |
| 12/06/2007 | US20070281339 Methods For Obtaining Optically Active Epoxides and Vicinal Diols From Styrene Oxides |
| 12/06/2007 | US20070281327 Methods of Screening for Modified Antibodies With Agonistic Activities |
| 12/06/2007 | US20070281323 Methods Of Detecting Lp-PLA2 Activity |
| 12/06/2007 | US20070281320 Novel Bioactive Lipid Derivatives, and Methods of Making and Using Same |
| 12/06/2007 | US20070281318 Use of monoclonal antibodies to distinguish protein conformational isoforms |
| 12/06/2007 | US20070281306 Novel 15571, 2465, 14266, 2882, 52871, 8203 and 16852 molecules and uses therefor |
| 12/06/2007 | US20070280951 Cell Death Inducing Agents |
| 12/06/2007 | US20070280950 Inflammatory Cytokine Inhibitors |
| 12/06/2007 | US20070280949 Combination Therapy for Gastroenteric Diseases Caused by Microorganisms |
| 12/06/2007 | US20070280946 Antibody to 5' -Deoxy-5' - Methylthioadenosine And Uses Thereof |
| 12/06/2007 | US20070280945 Human antibody or antigen-binding fragment which binds human IL-6 receptor (hIL-6R) with a KD of about <500 pM and blocks IL-6 activity with an IC50 of <200 pM;low dissociation kinetics; pharmakinetics; anticarcinogenic agents; melanoma; antitumor agents; antiarthritis agents; antiinflammatory agents |
| 12/06/2007 | US20070280941 Vcam-1 specific monoclonal antibody |
| 12/06/2007 | US20070280939 Prostatic Acid Phosphatase Antigens |
| 12/06/2007 | US20070280938 Peptides Derived from Natural Cytotoxicity Receptors and Methods of Use Thereof |
| 12/06/2007 | US20070280937 Compositions and Methods for the Treatment and Diagnosis of Neoplastic and Infectious Diseases |
| 12/06/2007 | US20070280935 Antibody that recognizes phosphorylated peptides |
| 12/06/2007 | US20070280932 Binding to monoclonal antibodies; antitumor agents |
| 12/06/2007 | US20070280931 Antibody variants |
| 12/06/2007 | US20070280930 Cd44-Targeting for Reducing/Preventing Ischemia-Reperfusion-Injury |
| 12/06/2007 | US20070280882 Engineered anti-cd20 antibody fragments for in vivo targeting and therapeutics |
| 12/06/2007 | US20070280881 Dimeric antibody having two antibodies that are non-covalently associated to form a tetravalent antibody dimer having four antigen-biding sites; neoplastic disorders such as colon cancer; autoimmune disorders |
| 12/06/2007 | CA2653931A1 Immune-derived moieties reactive against lysophosphatidic acid |
| 12/06/2007 | CA2653926A1 Methods and reagents for detecting bioactive lipids |
| 12/06/2007 | CA2653923A1 Novel bioactive lipid derivatives, immune-derived moieties reactive thereto, and methods of making and using the same |
| 12/06/2007 | CA2653717A1 Methods for site-specific pegylation |
| 12/06/2007 | CA2653661A1 Humanized anti-human osteopontin antibody |
| 12/06/2007 | CA2653339A1 Genetic markers for high oleic acid content in plants |
| 12/06/2007 | CA2652945A1 Antibodies and immunoconjugates and uses therefor |
| 12/06/2007 | CA2652895A1 Expression of the cysteine protease legumain in vascular and inflammatory diseases |
| 12/06/2007 | CA2652733A1 Modified humanised anti-interleukin-18 antibodies |
| 12/05/2007 | EP1862804A1 Method for diagnosis of prostate cancer |
| 12/05/2007 | EP1862551A1 Genetic markers for high oleic acid content in plants |
| 12/05/2007 | EP1862549A2 Target of RNAIII activating protein (TRAP) |
| 12/05/2007 | EP1862548A1 Death domain containing receptor 4 (DR4 : death receptor 4), member of the TNF-receptor superfamily and binding to trail (APO2-L) |
| 12/05/2007 | EP1862544A1 Polypeptides capable of eliciting an immune reaction against cancer |
| 12/05/2007 | EP1862472A2 Chlamydia protein, gene sequence and uses thereof |
| 12/05/2007 | EP1862179A1 Novel use of sulfonamide compound in combination with angiogenesis inhibitor |
| 12/05/2007 | EP1862178A1 Use of HLTF antibodies for diagnosis and treatment of cancer |
| 12/05/2007 | EP1861497A1 Protein and its use in diagnosing alzheimer's disease |
| 12/05/2007 | EP1861425A2 Anti-mesothelin antibodies |
| 12/05/2007 | EP1861424A2 Human monoclonal antibodies against hendra and pipah viruses |
| 12/05/2007 | EP1861423A1 Molecules and chimeric molecules thereof |
| 12/05/2007 | EP1861422A2 Screening method, process for purifying of non-diffusible a-beta oligomers, selective antibodies against said non-diffusible a-beta oligomers and a process for manufacturing of said antibodies |
| 12/05/2007 | EP1861123A2 Synergistic efect of tgf-beta blockade and immunogenic agents on tumors |
| 12/05/2007 | EP1635692A4 Monitoring immunologic, hematologic and inflammatory diseases |
| 12/05/2007 | EP1511861A4 Methods and compositions for milieu-dependent binding of a targeted agent to a target |
| 12/05/2007 | EP1509166B1 Method for improving body weight gain and feed conversion efficiency in animals |
| 12/05/2007 | EP1434483B1 Nucleic acids encoding linked chromo/fluorescent domains and methods for using the same |
| 12/05/2007 | EP0941252B1 Anti-p53 single-chain antibody fragments and their uses |
| 12/05/2007 | EP0931149B1 A novel haemopoietin receptor and genetic sequences encoding same |
| 12/05/2007 | EP0708831B2 Cell-density enhanced protein tyrosine phosphatases |
| 12/05/2007 | CN101084436A Methods for identifying compounds for regulating muscle mass or function using dopamine receptors |
| 12/05/2007 | CN101084317A Suppression of endogenous immunoglobulin expression |
| 12/05/2007 | CN101084233A Methods for reducing or eliminating alpha-mannosidase resistant glycans for the production of glycoproteins |
| 12/05/2007 | CN101084014A Single domain antibodies against tnfr1 and methods of use therefor |
| 12/05/2007 | CN101084013A Cancerous disease modifying antibodies |
| 12/05/2007 | CN101081869A Humanized antibodies that recognize beta amyloid peptide |
| 12/05/2007 | CN101081868A Humanized antibodies that recognize beta amyloid peptide |
| 12/05/2007 | CN101081867A Humanized antibodies that recognize beta amyloid peptide |
| 12/05/2007 | CN101081866A Domestic animal and aquatic product causal agent resistant specific IgY or compound IgY and application thereof |
| 12/05/2007 | CN101081863A Lipopolysaccharide conjugated protein and monoclonal antibody and preparation method and usage |
| 12/05/2007 | CN100352924C BASB 111 polypeptide and polynucleotide from moraxella cathraahalis |
| 12/05/2007 | CN100352844C Recombinant anti-osteopontin antibody and use thereof |
| 12/05/2007 | CN100352832C Oligopeptides for promoting hair growing |
| 12/05/2007 | CN100352501C Cripto blocking antibodies and uses thereof |
| 12/05/2007 | CN100352500C Stable liquid formulations of antibodies |
| 12/05/2007 | CN100352497C Antibody inhibition body fluid immunity of using special integrated CD40CR(CD40 part) |
| 12/05/2007 | CN100352493C Method of treating tumors |
| 12/04/2007 | US7304150 Methods and compositions for the prevention and treatment of anemia |
| 12/04/2007 | US7304145 Wound healing agents; anticancer agents; cardiovascular disorders |
| 12/04/2007 | US7304144 Antibodies binding to human TSLP Polypeptides |
| 12/04/2007 | US7304143 Nucleotide sequences coding polypeptides for use in the diagnosis, prevention and treatment of cell proliferative disorders |
| 12/04/2007 | US7304142 Mammalian MDM2 binding proteins |
| 12/04/2007 | US7304141 Human leucine-rich repeat containing protein expressed predominately in bone marrow, HLRRBM1 |
| 12/04/2007 | US7304140 For stimulating release of tumor necrosis factor, and/or cellular proliferation/differentiation of chondrocytes/pericytes/adipocytes/endothelial cells by contacting blood with polypeptide; cancer diagnosis |
| 12/04/2007 | US7304139 Polynucleotides and polypeptides of Anaplasma phagocytophilum and methods of using the same |
| 12/04/2007 | US7304136 PRO4407 polypeptides |
| 12/04/2007 | US7304135 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of cell proliferative and tumor disorders |
| 12/04/2007 | US7304134 PRO9742 polypeptides |
| 12/04/2007 | US7304128 High affinity and specificity, separation and immobilization of these structures for the fabrication of nano-devices |
| 12/04/2007 | US7303914 Monoclonal antibody against human hepatoma and use thereof |